Skip to content
Screener

Nature's Sunshine Products NATR General health — Net Sales

Other product segments

Digestive
$28.71M+2.9%
Cardiovascular
$19.83M+1.9%
Immunity
$8.73M-13.4%
Personal care
$6.76M+27.4%
Weight management
$4.06M-12.0%

Similar metrics at other companies

Perrigo Company logo
PRGODigestive Health — Net Sales
$115.7M-3.4%
Perrigo Company logo
PRGOSkin Health — Net Sales
$161.8M-5.0%
Perrigo Company logo
PRGOWomen's Health — Net Sales
$64.8M+3.3%
NN logo
NNBRGeneral Industrial — Net Sales
$31.33M+69.9%
CONMED logo
CNMDGeneral Surgery — Net Sales
$191.17M-5.2%
Walmart logo
WMTGeneral merchandise — Net Sales
$29.07B+4.5%

Other financials

Income statement

See full
Revenue$117.0M+1.9%
Gross profit$86.2M+4.7%
Operating income$5.5M+28.2%
Net income$3.5M-33.7%
EPS (diluted)$0.19-32.1%

Balance sheet

See full
Cash & equivalents$82.5M+1.4%
Total debt$21.4M+37.1%
Total equity$169.3M+3.4%
Total assets$259.8M+1.9%

Cash flow

See full
Operating cash flow-$1.8M-171%
CapEx$2.8M+106%
Free cash flow-$1.9M-165%

Valuation

See full
Market cap$288.04M-2.3%
Enterprise value$226.97M-0.8%
P/E15.9×-4.5×
P/S0.6×-0.1×

Profitability

See full
Gross margin73.2%+1.4pp
Operating margin6%+1.6pp
Net margin3.7%+0.5pp
FCF margin3.7%-1.2pp

Returns & leverage

See full
Return on equity10.9%+1.9pp
Debt / equity0.1×0.0×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Nature's Sunshine Products in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Nature's Sunshine Products’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054468
Three Months Ended June 30, 2026AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$21,486$9,589$16,242$1,582$48,899
Immune3,0791,8833,3214478,730
Cardiovascular12,8252,8953,71339819,831
Digestive9,6016,50710,0812,51928,708
Personal care3,5301,1241,8792236,756
Weight management2,4766967151744,061
Total net sales by segment$52,997$22,694$35,951$5,343$116,985

Item 1. Financial Statements (Unaudited)

FAQ

What is Nature's Sunshine Products's general health — net sales?
Nature's Sunshine Products (NATR) reported general health — net sales of $48.9M in Q2 2026.
How has Nature's Sunshine Products's general health — net sales changed year-over-year?
Nature's Sunshine Products's general health — net sales increased by 3.2% year-over-year, from $47.38M to $48.9M.
What is the long-term trend for Nature's Sunshine Products's general health — net sales?
Over 4 years (2021 to 2025), Nature's Sunshine Products's general health — net sales has grown at a 4.2% compound annual growth rate (CAGR), from $163M to $192.12M.
What does general health — net sales mean?
This metric represents the total revenue generated from the sale of nutritional and wellness products categorized under the general health segment. It reflects the market demand for the company's core health-focused offerings and serves as a primary indicator of the segment's contribution to overall corporate top-line performance. Monitoring this figure helps investors assess the growth trajectory and consumer adoption of the company's foundational product portfolio.

Ask your AI about Nature's Sunshine Products's general health — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude